Table 2 Clinical characteristics of the participants subjected to euglycemic hyperinsulinemic clamp

Age (years)^a

40 ± 9

38 ± 8

43 ± 11

Weight (kg)^a

75 ± 15

69 ± 11

80 ± 16

BMI (kg/m²)^a

27.3 ± 5.0

24.9 ± 3.7

29.8 ± 5.0

Postmenopausal (n)

6

1

5

Waist-to-hip ratio (A.U.)^a

0.9 ± 0.1

0.8 ± 0.0

0.9 ± 0.1

fP-glucose^b (mmol/l)^a

5.2 ± 0.6

5.0 ± 0.7

5.4 ± 0 ± 0.5

fS-insulin^c (mU/l)^a

4.1 ± 1.6

3.5 ± 1.2

4.8 ± 1.7

M-value^d (mg/kgBW/min)^a

6.4 ± 1.8

7.8 ± 1.1

5.0 ± 1.2

Body fat (%)^a

32.9 ± 7.2

30.1 ± 7.2

35.7 ± 6.2

SAT by MRI (cm³)^a

4111 ± 2189

2893 ± 1517

5328 ± 2103

C-peptide (nmol/l)^a

0.58 ±  + .18

0.51 ± 0.11

0.66 ± 0.20